TY - JOUR
T1 - Risk factors for recurrence amongst high intermediate risk patients with endometrioid adenocarcinoma
AU - Bahng, Agnes Y.
AU - Chu, Christina
AU - Wileyto, Paul
AU - Rubin, Stephen
AU - Lin, Lilie L.
PY - 2012
Y1 - 2012
N2 - Objective: To determine risk factors associated with recurrence in patients with high intermediate risk (HIR) endometrioid adenocarcinoma. Methods: A retrospective analysis of patients with HIR endometrioid adenocarcinoma who underwent hysterectomy, bilateral salpingo-oophorectomy, with or without pelvic/para-aortic lymphadenectomy at the University of Pennsylvania between 1990 and 2009 was performed. Results: A total of 103 women with HIR endometrial cancer were identified. Multivariable analysis revealed that ≥2/3 myometrial invasion (HR, 4.79; p=0.010) and grade 3 disease (HR, 3.04; p=0.045) were independently predictive of distant metastases. The 5-year distant metastases free survival (DMFS) for patients with neither or one of these risk factors was 89%, and the 5-year DMFS for patients with both risk factors was 48% (p<0.001). Conclusion: Patients with both grade 3 disease and deep third myometrial invasion have a high risk of distant metastases. Identifying these patients may be important in rationally selecting patients for systemic therapy.
AB - Objective: To determine risk factors associated with recurrence in patients with high intermediate risk (HIR) endometrioid adenocarcinoma. Methods: A retrospective analysis of patients with HIR endometrioid adenocarcinoma who underwent hysterectomy, bilateral salpingo-oophorectomy, with or without pelvic/para-aortic lymphadenectomy at the University of Pennsylvania between 1990 and 2009 was performed. Results: A total of 103 women with HIR endometrial cancer were identified. Multivariable analysis revealed that ≥2/3 myometrial invasion (HR, 4.79; p=0.010) and grade 3 disease (HR, 3.04; p=0.045) were independently predictive of distant metastases. The 5-year distant metastases free survival (DMFS) for patients with neither or one of these risk factors was 89%, and the 5-year DMFS for patients with both risk factors was 48% (p<0.001). Conclusion: Patients with both grade 3 disease and deep third myometrial invasion have a high risk of distant metastases. Identifying these patients may be important in rationally selecting patients for systemic therapy.
KW - Chemotherapy
KW - Endometrial neoplasms
KW - High intermediate risk
KW - Radiotherapy
UR - http://www.scopus.com/inward/record.url?scp=84867186124&partnerID=8YFLogxK
UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=purepublist2023&SrcAuth=WosAPI&KeyUT=WOS:000309041200008&DestLinkType=FullRecord&DestApp=WOS
U2 - 10.3802/jgo.2012.23.4.257
DO - 10.3802/jgo.2012.23.4.257
M3 - Article
C2 - 23094129
SN - 2005-0380
VL - 23
SP - 257
EP - 264
JO - Journal of Gynecologic Oncology
JF - Journal of Gynecologic Oncology
IS - 4
ER -